Inflammasome-targeted therapy might prevent adverse perinatal outcomes of recurrent chronic intervillositis of unknown etiology.
Mattuizzi A, Sauvestre F, Fargeix T, White E, Leibler C, Cargou M, Dugot-Senant N, Douchet I, Duluc D, Bordes C, Truchetet MÉ, Richez C, Forcade É, Duffau P, Viallard JF, Sentilhes L, Blanco P, Lazaro E.
Mattuizzi A, et al. Among authors: leibler c.
Nat Commun. 2024 Oct 30;15(1):9396. doi: 10.1038/s41467-024-53591-w.
Nat Commun. 2024.
PMID: 39477918